A prospective combined analysis of the ASPIRE and WARFASA: multi-centre, randomised, double-blind, placebo-controlled clinical trials examining the efficacy and safety of low-dose aspirin after initial anticoagulation to prevent recurrent venous thromboembolism

Pas encore traduit Pas encore traduit
Auteurs
Catégorie Primary study
Registry of TrialsANZCTR
Year 2011

Cet article est inclus dans 1 Systematic review Systematic reviews (1 reference)

This article is part of the following publication threads:
  • WARFASA [Warfarin and Aspirin] (4 documents)
  • ASPIRE [Aspirin to Prevent Recurrent Venous Thromboembolism] (4 documents)
Loading references information
Cet article n'a pas de résumé
Epistemonikos ID: 18ca41346e3f5e2c0da2858bf45f8044b2e5682c
First added on: Apr 23, 2018